Blockade of endothelial to mesenchymal transition (EndMT) by an inhibitor of histone methyltransferase EZH2 attenuates atherosclerosis in diabetes
Event:
ESC Congress 2024
Topic:
Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session:
Targeting endothelial function